Assignee
XAVIER UNIV OF LOUISIANA
US·9 granted patents·8 pending applications·2 citations·filing 2013–2024
Top patents by PatentIndex Score
17 records- 0172US10112962B2Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) groupXAVIER UNIV OF LOUISIANA·Filed 2015·Granted Oct 30, 2018·2 cites·6 claims
- 0269US2023406804A1Protein kinase inhibitorsXAVIER UNIV OF LOUISIANA·Filed 2023·Application pending·0 cites
- 0362US12258315B2S6K1 protein kinase inhibitors as cancer therapeuticsXAVIER UNIV OF LOUISIANA·Filed 2023·Granted Mar 25, 2025·0 cites·16 claims
- 0457US2021355060A1Protein kinase inhibitorsXAVIER UNIV OF LOUISIANA·Filed 2019·Application pending·0 cites
- 0554US11912660B2S6K1 protein kinase inhibitors as cancer therapeuticsXAVIER UNIV OF LOUISIANA·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 0650US9650369B2Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative diseaseXAVIER UNIV OF LOUISIANA·Filed 2013·Granted May 16, 2017·0 cites·20 claims
- 0750US2025100963A1Sulfonated and phosphorylated aromatic moleculesXAVIER UNIV OF LOUISIANA·Filed 2024·Application pending·0 cites
- 0848US11708381B2Inhibitors of androgen receptor signalingXAVIER UNIV OF LOUISIANA·Filed 2017·Granted Jul 25, 2023·0 cites·21 claims
- 0946US2024010602A1Phenyl unsaturated ketones as human factor xiiia inhibitors for treatment of thromboembolic diseasesXAVIER UNIV OF LOUISIANA·Filed 2023·Application pending·0 cites
- 1045US2022378721A1Protein kinase inhibitors and use thereof for treatment of neurodegenerative diseasesXAVIER UNIV OF LOUISIANA·Filed 2020·Application pending·0 cites
- 1144US11046715B2Boronic derivatives of hydroxamates as anticancer agentsXAVIER UNIV OF LOUISIANA·Filed 2017·Granted Jun 29, 2021·0 cites·19 claims
- 1241US10017475B2Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancerXAVIER UNIV OF LOUISIANA·Filed 2015·Granted Jul 10, 2018·0 cites·11 claims
- 1339US12109510B2Methods of solvent removal at ambient temperatures—cryovapXAVIER UNIV OF LOUISIANA·Filed 2020·Granted Oct 8, 2024·0 cites·19 claims
- 1439US2019233442A1Selective estrogen receptor down-regulators (serds)XAVIER UNIV OF LOUISIANA·Filed 2017·Application pending·0 cites
- 1539US2018200279A1Inhibition of hsv-1-associated corneal neovascularization using inhibitors of cyclin-dependent kinase 9XAVIER UNIV OF LOUISIANA·Filed 2015·Application pending·0 cites
- 1636US9636299B2Method for treating diabetic retinopathyXAVIER UNIV OF LOUISIANA·Filed 2013·Granted May 2, 2017·0 cites·2 claims
- 1734US2022041629A1Estrogen receptor targeting antagonistsXAVIER UNIV OF LOUISIANA·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XAVIER UNIV OF LOUISIANA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →